科前生物(688526.SH)：2025年度净利润4.16亿元，同比增加8.70%

Core Viewpoint - The company reported a steady growth in revenue and net profit for the fiscal year 2025, indicating resilience in a competitive market environment [1] Financial Performance - The company achieved an operating revenue of 950 million yuan in 2025, representing an increase of 0.89% compared to the previous year [1] - The net profit attributable to the parent company was 416 million yuan, reflecting an increase of 8.70% year-on-year [1] Industry Context - As of the end of 2025, the national pig inventory reached 42.967 million heads, an increase of 2.24 million heads, or 0.5% year-on-year [1] - The company has been focusing on enhancing its market competitiveness through increased research and development efforts and accelerating the progress of new product development [1]